Delivery Order SPE2DE21D0029-SPE2D626F05B7
- Not listed
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, received a delivery order valued at $1,786.65 from the Department of Defense's Medical Supply Chain on July 31, 2025. The contract is a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. Performance will be completed by August 21, 2025, at BD's facility in Sparks Glencoe,...
- Becton, Dickinson and Company's Infectious Disease Systems (IDS) division was awarded a delivery order valued at $2,143.98 by the Department of Defense's Medical Supply Chain on October 7, 2025, with an ultimate completion date of October 29, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting the company's competitive standing as a large, established medical technology manufacturer. The work will be performed in Sparks Glencoe,...
- Becton, Dickinson and Company's Diagnostic Systems (IDS) division has been awarded a delivery order valued at $1,786.65 by the Department of Defense's Medical Supply Chain division for performance in Sparks Glencoe, Maryland. This fixed-price delivery order with economic price adjustment provisions was awarded on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract utilizes no small business set-aside designation, reflecting BD's competitive position as a large,...
- The U.S. Department of Defense Medical Supply Chain awarded a $3,573.30 fixed-price delivery order to Becton, Dickinson and Company (BD), Infectious Disease Systems division, on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and represents a task order under BD's existing federal contract vehicles. The work will be performed at BD's facility in Sparks Glencoe, Maryland. BD, a global medical technology...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, was awarded a $55,450 firm fixed-price purchase order by the Bureau of Medicine and Surgery (a Defense agency component) on September 17, 2020, for a Comprehensive Service Plan with an ultimate completion date of September 17, 2025. The contract includes an exercised option year 1 and will be performed in Silver Spring, Maryland. This award was made on a full and open competition basis without set-aside...
- Becton, Dickinson and Co (BD) was awarded a $437,837.49 firm fixed-price delivery order on September 24, 2025, by the Defense Health Agency's Medical Supply Chain division for medical supplies and equipment. The contract, which carries no small business set-aside designation, has an ultimate completion date of October 28, 2026, and will be performed at BD's facility in Franklin Lakes, New Jersey. As a leading global medical technology manufacturer, BD will deliver specialized medical devices and...
- Becton, Dickinson and Company's Infectious Disease Systems division received a delivery order award on December 10, 2025, for the Kit Affirm VPIII Clinical under a fixed-price contract with economic price adjustment provisions. The award, valued at $1,361.04 with an ultimate completion date of January 2, 2026, supports the Defense Health Agency's Medical Supply Chain operations. The work will be performed in Sparks, Maryland. This delivery order was issued without a small business set-aside...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a $554,676.21 firm fixed-price delivery order by the Defense Health Agency for microbiology testing reagents and related services at Fort Belvoir, Virginia. This contract, issued on October 1, 2020, with a completion date of September 30, 2025, represents a task order under BD's established Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract. The award was made...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, has been awarded a delivery order for plastic BACTEC Plus Aerobic bottles used for pediatric bacterial enumeration and culturing techniques. This firm fixed-price delivery order, awarded by the Defense Health Agency on October 8, 2021, carries a ceiling value of $291,360 and is scheduled for completion by September 30, 2026. The order will be performed in Portsmouth, Virginia, and represents a non-set-aside procurement,...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D626F05B7Delivery Order
Becton, Dickinson and Company's Infectious Disease Systems division received a $1,122.00 delivery order award from the Defense Department's Medical Supply Chain on December 10, 2025, for tube culture media products (specifically 7ML BD BCTC BD MGIT BRCD MYCB items) with performance completion targeted for January 2, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and will be performed in Sparks, Maryland. This delivery order represents a child award issued under a larger indefinite delivery vehicle, consistent with BD's established role as a primary supplier of diagnostic laboratory equipment and consumables to federal healthcare agencies. BD maintains an extensive portfolio of federal contracts valued at over $500 million in prime awards, positioning the company as a critical supplier of advanced diagnostic technologies including blood culture systems, microbiology analyzers, molecular testing capabilities, and related reagents. The award carries no small business set-aside designation, reflecting BD's competitive position as a large, established manufacturer. This procurement aligns with the company's substantial contracting history across the Department of Veterans Affairs, Defense Health Agency, National Institutes of Health, and other federal healthcare entities, where BD provides diagnostic equipment, laboratory instrumentation, and testing supplies supporting clinical diagnostics and military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/9/25 |